Akoya Biosciences's total assets for Q3 2024 were $129.97M, a decrease of -9.58% from the previous quarter. AKYA total liabilities were $116.34M for the fiscal quarter, a -4.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.